Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Potential function for the ROS-generating activity of TRACP.

Jussi M Halleen1, Seija R Räisänen, Sari L Alatalo

  • 1Institute of Biomedicine, Department of Anatomy, University of Turku, Turku, Finland.

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|October 31, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insights into immuno-oncology drug development landscape with focus on bone metastasis.

Frontiers in immunology·2023
Same author

Osteoimmuno-Oncology: Therapeutic Opportunities for Targeting Immune Cells in Bone Metastasis.

Cells·2021
Same author

Immunotherapies and Metastatic Cancers: Understanding Utility and Predictivity of Human Immune Cell Engrafted Mice in Preclinical Drug Development.

Cancers·2020
Same author

Human Immune System Increases Breast Cancer-Induced Osteoblastic Bone Growth in a Humanized Mouse Model without Affecting Normal Bone.

Journal of immunology research·2019
Same author

Dovitinib dilactic acid reduces tumor growth and tumor-induced bone changes in an experimental breast cancer bone growth model.

Journal of bone oncology·2019
Same author

Alendronate-induced disruption of actin cytoskeleton and inhibition of migration/invasion are associated with cofilin downregulation in PC-3 prostate cancer cells.

Oncotarget·2018

Tartrate-resistant acid phosphatase (TRACP) generates reactive oxygen species (ROS) in osteoclasts and macrophages. This ROS activity is crucial for bone resorption and immune defense against pathogens like Staphylococcus aureus.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Immunology

Background:

  • Tartrate-resistant acid phosphatase (TRACP) is an enzyme primarily expressed in osteoclasts and macrophages.
  • Its biological function remains largely unknown, despite its known phosphatase activity.

Purpose of the Study:

  • To investigate the biological function of TRACP, focusing on its reactive oxygen species (ROS) generating capacity.
  • To explore the role of TRACP-mediated ROS in bone resorption and immune responses.

Main Methods:

  • Localization studies of TRACP in transcytotic vesicles within osteoclasts.
  • Analysis of TRACP's colocalization with Staphylococcus aureus in macrophages.
  • Assessment of ROS generation by TRACP in both cell types.

Related Experiment Videos

Main Results:

  • TRACP generates reactive oxygen species (ROS), contributing to organic bone matrix degradation within osteoclasts.
  • TRACP is involved in the antigen presentation pathway in macrophages, with elevated ROS levels observed.
  • TRACP-deficient mice show reduced clearance of Staphylococcus aureus, indicating a role in immune defense.

Conclusions:

  • TRACP's ROS-generating activity plays a significant role in bone resorption by degrading matrix components.
  • TRACP contributes to the immune defense system by generating ROS to eliminate pathogens within macrophages.